Life Insurance and GLP-1 Telehealth: Does It Show Up on Your MIB Report?
If you apply for life insurance, the insurer will pull your MIB report and your prescription history. People ask whether a telehealth GLP-1 — especially a cash-pay one — shows up there. The answer is more interesting than a simple yes or no.
What MIB actually is
The Medical Information Bureau is a nonprofit membership organization that acts as a clearinghouse for life, health, and disability insurance underwriters. When you apply for individually underwritten life insurance, the insurer typically checks MIB to see if any prior application disclosed conditions or test results that are material to risk.
A few things people misunderstand about MIB:
- It is not a medical record. It does not contain your prescriptions, your diagnoses from your doctor, or your treatment history.
- It contains coded information from prior insurance applications. If you applied for life insurance in 2019 and disclosed elevated blood pressure, that is coded and stored.
- Entries come from member insurance companies, not from pharmacies, doctors, or telehealth platforms.
- You have a right to see your own MIB file (free once per year under federal law, via the MIB consumer request process).
So the direct answer: a cash-pay GLP-1 prescription from a telehealth platform does not, by itself, generate an MIB entry. The telehealth platform is not an MIB member. No one from your platform is reporting anything to MIB.
The separate report: your prescription history
Here's the twist. Most life insurance underwriters don't stop at MIB. They also pull a prescription history report from services like Milliman IntelliScript or ExamOne ScriptCheck. These services aggregate prescription data from pharmacy benefit managers and, in some cases, cash-pay pharmacies.
What shows up on a prescription history report depends on the data source:
| Path | Appears on Rx history? |
|---|---|
| Prescription filled through your insurance at a retail pharmacy | Yes, almost always |
| Prescription paid cash at a retail pharmacy (CVS, Walgreens) using your name and ID | Usually yes — retail pharmacies report to PBMs even for cash transactions |
| Prescription from a 503A compounding pharmacy shipped directly to you | Often no — compounding pharmacies don't consistently report to these services |
| Brand-name prescription from a 503B outsourcing facility or specialty pharmacy | Variable; often yes if it runs through standard pharmacy networks |
What you're obligated to disclose
Now the important part. Life insurance applications ask questions under penalty of perjury. Typical questions include:
- Have you been diagnosed with or treated for diabetes or obesity in the last 5 years?
- Are you currently taking any prescription medications?
- Have you been hospitalized or had any surgical procedures?
- Have you been advised to lose weight by a physician?
If you are currently prescribed a GLP-1, you almost certainly have to disclose it in response to the "prescription medications" question, regardless of whether you think the insurer will find out. Material misrepresentation on a life insurance application can result in:
- Denial of the application
- Rescission of the policy within the contestability period (usually the first two years)
- Death benefit denial if the misrepresentation is discovered during a contestability-period claim
- In egregious cases, fraud charges
The two-year contestability period is the critical detail. If someone dies within two years of issuance and the insurer can show material misrepresentation on the application, the death benefit can be reduced to a refund of premiums.
Underwriting implications of a GLP-1
How does disclosing a GLP-1 affect your life insurance rates? It depends on why you're taking it.
If you're taking a GLP-1 for Type 2 diabetes
The underwriter is evaluating the diabetes, not the GLP-1. Life insurance rates for Type 2 diabetes depend on age of diagnosis, most recent A1c, presence of complications, and other risk factors. The GLP-1 is generally viewed favorably because it indicates treatment compliance and good glycemic control.
If you're taking a GLP-1 for obesity
This is more nuanced. Obesity is a risk factor priced into life insurance rates. If your current BMI qualifies you for a standard or better rate, being on a GLP-1 is often underwriting-neutral or slightly favorable. If you've lost significant weight, some insurers will wait for you to maintain the loss for a period (often 12 months) before rating you at the lower-BMI tier.
If you're taking a GLP-1 off-label for weight loss with no formal diagnosis
Insurers evaluate on the medical record and the prescription history. If you disclose it and your records show no diabetes diagnosis, the underwriter may ask follow-up questions about the prescribing indication.
Five things that actually matter
- MIB itself will not show your GLP-1. It's not a prescription database.
- Prescription history reports may or may not show a cash-pay compounded GLP-1. Don't rely on this as a disclosure strategy.
- You must disclose current prescriptions on a life insurance application regardless of what you think will be in the reports. Misrepresentation is a rescission risk.
- If you've recently stopped a GLP-1, some insurers will ask when and why. Treatment compliance looks favorable; erratic use is less so.
- Pull your own MIB report and prescription history before applying for life insurance. You'll apply more confidently and catch any errors. MIB is free annually; IntelliScript and ScriptCheck reports can be requested under FCRA.
The broader principle
People ask about MIB because they want a framework for understanding what's visible to insurers. The framework is actually simpler than the folklore: life insurance underwriting is driven by what you disclose, cross-checked against what's in the databases. If those two line up, underwriting goes smoothly. If they don't, the applications gets flagged, delayed, and often denied.
Cash-pay compounded telehealth GLP-1s are harder to discover independently, but that doesn't change your obligation to disclose. The honest advice is: take the medication that's right for you, document your care well, and when insurance time comes, tell the truth. The rating you get will reflect the real picture — and it's often more favorable than people fear.